Showing 1 - 10 of 10
Persistent link: https://www.econbiz.de/10002055014
Persistent link: https://www.econbiz.de/10009720772
Persistent link: https://www.econbiz.de/10011542205
Persistent link: https://www.econbiz.de/10002576693
Persistent link: https://www.econbiz.de/10001372029
Persistent link: https://www.econbiz.de/10001038819
This paper examines the impact of coinsurance exemption for prescription medicines applied to elderly individuals in Spain after retirement. To evaluate this coinsurance change we use a rich administrative dataset that links pharmaceutical consumption and hospital discharge records for the full...
Persistent link: https://www.econbiz.de/10013121905
This paper examines the impact of coinsurance exemption for prescription medicines applied to elderly individuals in Spain after retirement. To evaluate this coinsurance change we use a rich administrative dataset that links pharmaceutical consumption and hospital discharge records for the full...
Persistent link: https://www.econbiz.de/10014178520
This article tries to reconcile economic-industrial policy with health policy when dealing with biomedical innovation and welfare state sustainability. Better health accounts for an increasingly large proportion of welfare improvements. Explanation is given to the welfare losses coming from the...
Persistent link: https://www.econbiz.de/10014061473
The aim of this paper is to assess whether cost-containment has been affected by recent pharmaceutical reimbursement reforms that have been introduced in the Spanish health care system over the period 1996-2002, under the conservative Popular Party government. Four main reimbursement policies...
Persistent link: https://www.econbiz.de/10014076118